Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,842 | -4,034 | -6,161 | -8,558 | -9,605 |
| Depreciation Amortization | 1,179 | 1,049 | 1,334 | 1,098 | 723 |
| Accounts receivable | 76 | -150 | 270 | 76 | -497 |
| Other Working Capital | -691 | 26 | 287 | -1,087 | -148 |
| Other Operating Activity | -140 | 423 | 321 | 745 | 2,325 |
| Operating Cash Flow | $-2,419 | $-2,686 | $-3,949 | $-7,725 | $-7,202 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,680 | 2,320 | 6,094 | -9,943 |
| PPE Investments | -138 | -22 | -58 | -3,091 | -2,446 |
| Other Investing Activity | -20 | -13 | -41 | -469 | -30 |
| Investing Cash Flow | $-158 | $1,645 | $2,222 | $2,533 | $-12,419 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -26 | -195 | -589 |
| Common Stock Issued | 3,201 | 30 | N/A | 1,023 | 27,409 |
| Common Stock Repurchased | N/A | N/A | -5 | -4 | N/A |
| Dividend Paid | -11 | -37 | N/A | N/A | -39 |
| Other Financing Activity | -180 | -264 | -72 | -168 | -14 |
| Financing Cash Flow | $3,010 | $-270 | $-102 | $656 | $26,769 |
| Beginning Cash Position | 1,679 | 2,991 | 4,820 | 9,356 | 2,208 |
| End Cash Position | 2,112 | 1,679 | 2,991 | 4,820 | 9,356 |
| Net Cash Flow | $433 | $-1,312 | $-1,829 | $-4,536 | $7,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,419 | -2,686 | -3,949 | -7,725 | -7,202 |
| Capital Expenditure | -138 | -22 | -58 | -3,091 | -2,446 |
| Free Cash Flow | -2,556 | -2,708 | -4,007 | -10,816 | -9,648 |